Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment - A GE Healthcare Companion Study: Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 (mTBI-phase2)

NCT03265912 is registered in ClinicalTrials.gov with ElMindA Ltd as lead sponsor.

NCT NCT03265912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03265912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment - A GE Healthcare Companion Study: Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 (mTBI-phase2)
Lead sponsor
ElMindA Ltd
Phase
Observational
Overall status
Completed
Start date
January 26, 2017
Completion date
January 16, 2018
Enrollment
46 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

concussion, mild, mild traumatic brain injury, tbi (traumatic brain injury)